Sonoma Pharmaceuticals (SNOA) Cash from Operations (2010 - 2026)
Sonoma Pharmaceuticals (SNOA) posted quarterly Cash from Operations of 519000.0 for Q1 2026, down 446.32% year-over-year from 149863.22 in Q1 2025, and up 32.07% quarter-over-quarter from 764000.0 in Q4 2025.
Sonoma Pharmaceuticals (SNOA) Cash from Operations (2010 - 2026) Analysis & Trends
Sonoma Pharmaceuticals' Cash from Operations history runs 17 years deep, the most recent figure standing at 519000.0 for Q1 2026.
- In Q1 2026, Cash from Operations fell 446.32% year-over-year to 519000.0; the TTM figure through Mar 2026 stood at 3933000.0 (down 4369.32% YoY), while the FY2026 annual figure was 3933000.0, down 4369.32% from the prior year.
- Cash from Operations for Q1 2026 stood at 519000.0, up from 764000.0 in the prior quarter.
- The five-year high for Cash from Operations was 565000.0 in Q4 2024, with the low at 2441000.0 in Q1 2023.
- The 5-year median for Cash from Operations is 764000.0 (2025), against an average of 821529.41.
- The sharpest annual moves came in 2024 and 2026: Cash from Operations jumped 151.18% in 2024, then plunged 446.32% in 2026.
- Sonoma Pharmaceuticals' Cash from Operations stood at 348000.0 in 2022, then slumped by 217.24% to 1104000.0 in 2023, then surged by 151.18% to 565000.0 in 2024, then slumped by 235.22% to 764000.0 in 2025, then surged by 32.07% to 519000.0 in 2026.
- Business Quant data shows SNOA's Cash from Operations at 519000.0 in Q1 2026, 764000.0 in Q4 2025, and 635000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 411.00 Mn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 655.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 800.69 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 313.60 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 381.80 Mn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 136.40 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 277.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Sonoma Pharmaceuticals | 5.12 Mn | -222,819.83 | 2.58 Mn | -649,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -649,000.00 |
| Jun 30, 2026 | -649,000.00 |
| Mar 31, 2026 | -519,000.00 |
| Mar 31, 2026 | -519,000.00 |
| Dec 31, 2025 | -764,000.00 |
| Dec 31, 2025 | -764,000.00 |
| Sep 30, 2025 | -635,000.00 |
| Sep 30, 2025 | -635,000.00 |
| Jun 30, 2025 | -2.02 Mn |
| Jun 30, 2025 | -2.02 Mn |
| Mar 31, 2025 | -95,000.00 |
| Mar 31, 2025 | -95,000.00 |
| Dec 31, 2024 | 565,000.00 |
| Dec 31, 2024 | 565,000.00 |
| Sep 30, 2024 | 354,000.00 |
| Sep 30, 2024 | 354,000.00 |
| Jun 30, 2024 | -912,000.00 |
| Jun 30, 2024 | -912,000.00 |
| Mar 31, 2024 | 152,000.00 |
| Mar 31, 2024 | 152,000.00 |